LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,113
تعداد مقالات10,208
تعداد مشاهده مقاله40,771,444
تعداد دریافت فایل اصل مقاله8,800,563
Nabavizadeh, Seyed Hesam, Almasi, Davoud, Askari, Aida, Alyasin, Soheila, Mortazavi, Negar, Esmaeilzadeh, Hossein. (1399). The prevalence of steroid phobia and its correlates among the parents of asthmatic children. سامانه مدیریت نشریات علمی, 7(1), 15-20. doi: 10.30476/tips.2021.89803.1077
Seyed Hesam Nabavizadeh; Davoud Almasi; Aida Askari; Soheila Alyasin; Negar Mortazavi; Hossein Esmaeilzadeh. "The prevalence of steroid phobia and its correlates among the parents of asthmatic children". سامانه مدیریت نشریات علمی, 7, 1, 1399, 15-20. doi: 10.30476/tips.2021.89803.1077
Nabavizadeh, Seyed Hesam, Almasi, Davoud, Askari, Aida, Alyasin, Soheila, Mortazavi, Negar, Esmaeilzadeh, Hossein. (1399). 'The prevalence of steroid phobia and its correlates among the parents of asthmatic children', سامانه مدیریت نشریات علمی, 7(1), pp. 15-20. doi: 10.30476/tips.2021.89803.1077
Nabavizadeh, Seyed Hesam, Almasi, Davoud, Askari, Aida, Alyasin, Soheila, Mortazavi, Negar, Esmaeilzadeh, Hossein. The prevalence of steroid phobia and its correlates among the parents of asthmatic children. سامانه مدیریت نشریات علمی, 1399; 7(1): 15-20. doi: 10.30476/tips.2021.89803.1077

The prevalence of steroid phobia and its correlates among the parents of asthmatic children

Trends in Pharmaceutical Sciences
مقاله 3، دوره 7، شماره 1، خرداد 2021، صفحه 15-20    اصل مقاله (341.09 K)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.30476/tips.2021.89803.1077
نویسندگان
Seyed Hesam Nabavizadeh1، 2؛ Davoud Almasi2؛ Aida Askari2؛ Soheila Alyasin1، 2؛ Negar Mortazavi3؛ Hossein Esmaeilzadeh* 1، 2
1Allergy Research center, Shiraz University of medical Sciences, Shiraz, Iran.
2Department of Allergy and Clinical Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
3Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Scienes, Shiraz, Iran
چکیده
Background: Asthma is chronic respiratory inflammatory disease with prevalence of 10-20% in children and 5-10% in adults. Main treatment of asthma constituted of inhaled corticosteroids (ICS) which can impede the progression of pathology in asthmatic patients. Potentially side effects of corticosteroids may prevent some patients from taking medication, which can increase exacerbation and and severity of asthma. We aimed to investigate the prevalence and reasons of fear towards corticosteroids in asthma patients.
Methods: In this cross-sectional study asthma patients viewpoint regarding inhaled and oral corticosteroids in the management of asthma was assessed using questionnaire. Exclusion criteria were the patients afflicted with chronic respiratory diseases other than asthma and the ones who were taking corticosteroids for other reasons. The data were analyzed using SPSS version 25.
Results: 50.7% of patients were male. The mean age of the subjects was 10.71 years and the mean duration of disease and treatment course were 3.2 and 2.2 years respectively. 75.4% of patients had regular follow-up. 56.6% did not know the mechanism of action of corticosteroids in asthma and 75.4% of patients had concerns regarding the adverse effects of corticosteroids. The most common concerns reported were drug dependency (14.9%) followed by osteoporosis (14.3%). 40.8% of patients claimed that they use corticosteroids with peace of mind if their physician prescribes them.
conclusion: 75%of patients had concerns regarding the adverse effects of corticosteroids and the most common concerns reported were drug dependency (14.9%).
کلیدواژه‌ها
asthma؛ corticosteroid؛ adverse effect؛ phobia
مراجع
1. Dennis RJ, Caraballo L, García E, Rojas MX, Rondon MA, Pérez A, Aristizabal G, Peñaranda A, Barragan AM, Ahumada V, Jimenez S. Prevalence of asthma and other allergic conditions in Colombia 2009–2010: a cross-sectional study. BMC Pulm Med. 2012 Dec 1;12(1):17.
2. Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res and Pract. 2017 Dec 1;3(1):1.
3. Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018 Feb 24;391(10122):783-800. doi: 10.1016/S0140-6736(17)33311-1. Epub 2017 Dec 19. PMID: 29273246.
4. Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax. 2007 Sep;62(9):758-66. doi: 10.1136/thx.2006.070169.
5. O'Byrne PM, Pedersen S, Schatz M, Thoren A, Ekholm E, Carlsson LG, Busse WW. The poorly explored impact of uncontrolled asthma. Chest. 2013 Feb 1;143(2):511-523. doi: 10.1378/chest.12-0412.
6. Donohue JF, Ohar JA. Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1(3):152-60. doi: 10.1513/pats.200402-003MS.
7. Larsen GL. Asthma in children. N Engl J Med. 1992 Jun 4;326(23):1540-5. doi: 10.1056/NEJM199206043262306. PMID: 1579137.
8. Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics. 2009 Mar;123(3):e519-25. doi: 10.1542/peds.2008-2867.
9. Rand CS. Non-adherence with asthma therapy: more than just forgetting. J Pediatr. 2005 Feb;146(2):157-9. doi: 10.1016/j.jpeds.2004.11.021. PMID: 15689896.
10. Brook U, Mendelberg A, Heim M. Increasing parental knowledge of asthma decreases the hospitalization of the child: a pilot study. J Asthma. 1993;30(1):45-9. doi: 10.3109/02770909309066379. PMID: 8428857.
11. Chambers CV, Markson L, Diamond JJ, Lasch L, Berger M. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med. 1999 Feb;93(2):88-94. doi: 10.1016/s0954-6111(99)90296-2. PMID: 10464858.
12. Ip KI, Hon KL, Tsang KYC, Leung TNH. Steroid phobia, Chinese medicine and asthma control. Clin Respir J. 2018 Apr;12(4):1559-1564. doi: 10.1111/crj.12705. Epub 2017 Oct 12. PMID: 28876537.
13. Philip J. The effects of inhaled corticosteroids on growth in children. Open Respir Med J. 2014;8:66-73. Published 2014 Dec 31. doi:10.2174/1874306401408010066
14. Becker AB, Kuznetsova O, Vermeulen J, Soto-Quiros ME, Young B, Reiss TF, et al. Pediatric Montelukast Linear Growth Study Group. Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study. Ann Allergy Asthma Immunol. 2006 Jun;96(6):800-7. doi: 10.1016/s1081-1206(10)61342-7. PMID: 16802767.
15. Zedan MM, Ezz El Regal M, A Osman E, E Fouda A. Steroid Phobia among Parents of Asthmatic Children: Myths and Truth. Iran J Allergy Asthma Immunol. 2010 Sep;9(3):163-8. PMID: 20952806.
16. Al-Jahdali HH, Al-Zahrani AI, Al-Otaibi ST, Hassan IS, Al-Moamary MS, Al-Duhaim AS, et al. Perception of the role of inhaled corticosteroids and factors affecting compliance among asthmatic adult patients. Saudi Med J. 2007 Apr;28(4):569-73. PMID: 17457479.
17. El Hachem M, Gesualdo F, Ricci G, Diociaiuti A, Giraldi L, Ametrano O, Occella C, Fortina AB, Milioto M, Arcangeli F, Simonetti O, Giancristoforo S, Calamelli E, Mazzatenta C, Neri I. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey. Ital J Pediatr. 2017 Feb 28;43(1):22. doi: 10.1186/s13052-017-0330-7. PMID: 28245844; PMCID: PMC5330138.
18. Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest. 1998 Mar;113(3):587-92. doi: 10.1378/chest.113.3.587. PMID: 9515829.
19. Alshamary, H. et al., 2018. Corticosteroid Phobia Among Parents of AsthmaticChildren and its Impact on Asthma managment in Hail Region. Int J Adv Res. 2018;6(5):390-8

آمار
تعداد مشاهده مقاله: 7,525
تعداد دریافت فایل اصل مقاله: 537


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب